Levine Mitchell S 4
4 · OncoCyte Corp · Filed Apr 20, 2020
Insider Transaction Report
Form 4
Levine Mitchell S
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares, no par value
2020-03-14+20,000→ 33,495 total - Exercise/Conversion
Restricted Stock Units
2020-03-14−20,000→ 0 totalExercise: $0.00→ Common Shares (20,000 underlying) - Tax Payment
Common Shares, no par value
2020-03-14−6,916→ 26,579 total
Footnotes (2)
- [F1]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 20,000 Restricted Stock Units, the grant of which was previously reported on a Form 4.
- [F2]Restricted Stock Units vested on March 14, 2020